Revenue from operations increased sequentially by 13% to Rs. 891 crores, down 2% year-on-year First half FY25 revenue was broadly flat, in line with our guidance, at Rs. 1,681 crores Syngene International Limited today announced its second quarter and half year financial results. Revenue from
Tremelimumab in combination with Durvalumab is indicated for the treatment of patients with unresectable hepatocellular carcinoma (uHCC) AstraZeneca Pharma India Ltd. (AstraZeneca India), a science-led biopharmaceutical company, announced it has received approval from the Central Drugs Standard Control Organisation (CDSCO) for its cancer drug Tremelimumab Concentrate
AstraZeneca Pharma India Ltd. (AstraZeneca India), a leading biopharmaceutical company, announced the appointment of Bhavana Agrawal as Chief Finance Officer (CFO) with effect from October 1, 2023, following a transition period. She succeeds Rajesh Marwaha, who is retiring as CFO and full-time director of the
AstraZeneca Pharma India Ltd a leading biopharmaceutical company announces a change in its leadership with the appointment of Dr. Sanjeev Panchal as Country President & Managing Director, AstraZeneca Pharma India Ltd with effect from 1st January 2023. Sanjeev has been with AstraZeneca for 19 years and
Dapagliflozin reduces the risk of sustained eGFR, cardiovascular deaths and hospitalization for heart failure in adults with CKD Indicated in adults for the treatment of patients of Chronic Kidney Disease up to eGFR greater than or equal to 25 ml per min per 1.73 m2 AstraZeneca
There is an urgent need to invest in healthcare systems to build resilience against future crises and the growing burden of disease, according to new research presented at a Global Summit today (22 November 2022). The research, commissioned by the Partnership for Health System Sustainability and
Results presented at European Society of Cardiology Congress 2022, and published in New England Journal of Medicine Data extend the clinically meaningful benefits of dapagliflozin in patients with heart failure regardless of ejection fraction Heart failure is a chronic, progressive disease impacting nearly 64
Sputnik V is playing the key role in the vaccination campaign in Mexico’s capital with over 3 million citizens of Mexico City already administered the Russian vaccine. The first component of Sputnik V (Sputnik Light) is also increasingly used in the city’s revaccination campaign as
Previous studies also demonstrated additional significant strengthening of protection against Omicron by Sputnik Light booster, which can also be a universal booster to other vaccines to strengthen and lengthen their protection against Omicron. A unique comparative study conducted at the Italian Spallanzani Institute, the leading
Bharat Biotech's Covaxin has been included to the approved list of COVID-19 vaccines for travel to Oman without Quarantine. In a tweet, Bharat Biotech noted: "Covaxin has now been added to the approved list of #COVID 19 vaccines for travel to Oman without quarantine. This will
